Dense-Dose Chemo of Little Benefit in Early Breast Cancer

Share this content:
Dense-Dose Chemo of Little Benefit in Early Breast Cancer
Dense-Dose Chemo of Little Benefit in Early Breast Cancer

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- Tailored dose-dense chemotherapy offers little benefit over standard chemotherapy for women with high-risk early breast cancer, according to research published in the Nov. 8 issue of the Journal of the American Medical Association.

Researchers from The Swedish Breast Cancer Group, led by Jonas Bergh, M.D., of the Karolinska Institute and University Hospital in Stockholm, randomly assigned 2,017 women to either a standard chemotherapy group or a tailored dose-dense group. All of the participants had had surgery for node-positive or high-risk node-negative breast cancer.

After five years, 88.7 percent of the dose-dense group and 85.0 percent of the standard group were alive and had no recurrence of cancer. In addition, the researchers found that 86.7 percent of the dose-dense group had event-free survival at five years, compared with 82.1 percent of the standard group. Those in the dose-dense group reported worse quality of life on parameters like sexual functioning and side effects such as fatigue.

"Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival," the authors write. "Nonhematologic toxic effects were more frequent in the tailored dose-dense group."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »